Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

NCT03315923 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Rituximab
DRUG: Glatiramer Acetate

Sponsor

Isfahan University of Medical Sciences